Detalles de la búsqueda
1.
Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study.
Eur Respir J;
61(4)2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36669777
2.
Gene expression profile of high PD-L1 non-small cell lung cancers refractory to pembrolizumab.
Cancer Immunol Immunother;
71(11): 2791-2799, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35435450
3.
Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer.
Eur Respir J;
56(6)2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32855221
4.
Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer.
Hum Mol Genet;
25(8): 1457-67, 2016 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26792177
5.
Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis.
Thorax;
73(2): 145-150, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28798214
6.
High quality standards for a large-scale prospective population-based observational cohort: Constances.
BMC Public Health;
16(1): 877, 2016 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27557750
7.
Relapsing pneumonitis due to two distinct inhibitors of the MAPK/ERK pathway: report of a case.
BMC Cancer;
15: 732, 2015 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26481107
8.
Baseline Hedgehog Pathway Activation and Increase of Plasma Wnt1 Protein Are Associated with Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer.
Cancers (Basel);
13(5)2021 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33807552
9.
Low income and outcome in idiopathic pulmonary fibrosis: An association to uncover.
Respir Med;
183: 106415, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33965849
10.
Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal?
Front Med (Lausanne);
8: 713698, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34422868
11.
Plasma Biomarkers Screening by Multiplex ELISA Assay in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
Cancers (Basel);
13(1)2020 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33396187
12.
Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression.
J Immunother Cancer;
8(1)2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32581058
13.
Positive plasma cotinine during platinum-based chemotherapy is associated with poor response rate in advanced non-small cell lung cancer patients.
PLoS One;
14(7): e0219080, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31260495
14.
Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab.
J Immunother Cancer;
7(1): 176, 2019 07 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31292005
15.
Clinical factors associated with early progression and grade 3-4 toxicity in patients with advanced non-small-cell lung cancers treated with nivolumab.
PLoS One;
13(4): e0195945, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29684049
16.
Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab.
Oncoimmunology;
7(8): e1452581, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30221046
17.
Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer.
Oncoimmunology;
7(5): e1424675, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29721388
18.
Paradoxical worsening of hypoxemia in a patient treated by noninvasive positive pressure ventilation for obesity hypoventilation syndrome with concomitant obstructive sleep apnea: a case report.
J Med Case Rep;
11(1): 234, 2017 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-28830548
19.
Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges.
Eur J Cancer;
78: 16-23, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28407528
20.
Molecular characterization of circulating tumor cells in lung cancer: moving beyond enumeration.
Oncotarget;
8(65): 109818-109835, 2017 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29312651